NASDAQ:CHEK Check-Cap (CHEK) Stock Price, News & Analysis → Biggest hedge fund manager has huge warning for U.S. dollar (From Stansberry Research) (Ad) Free CHEK Stock Alerts $2.17 -0.05 (-2.25%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range$2.17▼$2.2650-Day Range$1.87▼$3.1152-Week Range$1.30▼$4.63Volume5,245 shsAverage Volume184,677 shsMarket Capitalization$12.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Check-Cap alerts: Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. About Check-Cap Stock (NASDAQ:CHEK)Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.Read More CHEK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEK Stock News HeadlinesMay 9, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Check-Cap (NASDAQ:CHEK)May 1, 2024 | americanbankingnews.comCheck-Cap (NASDAQ:CHEK) Research Coverage Started at StockNews.comMay 10, 2024 | Stansberry Research (Ad)Do This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).March 26, 2024 | msn.comAI-Powered Real Estate Marketplace Nobul AI To Acquire Medical-Diagnostics Company Check-CapMarch 26, 2024 | investorplace.comWhy Is Check-Cap (CHEK) Stock Up 44% Today?March 25, 2024 | prnewswire.comNobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination AgreementMarch 19, 2024 | msn.comWhat the Chargers can do with their cap space after roster movesMarch 8, 2024 | msn.comHow much cap space do the Seahawks have after trio of Tuesday cuts?May 10, 2024 | Stansberry Research (Ad)Do This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).February 24, 2024 | jaguarswire.usatoday.comLarger than expected salary cap means more space for JaguarsFebruary 23, 2024 | msn.comBengals emerge big winners with updated cap space after 2024 cap revealFebruary 10, 2024 | investing.comCheck Cap Ltd (CHEK)December 22, 2023 | finance.yahoo.comSYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTDDecember 14, 2023 | finance.yahoo.comCheck-Cap Board of Directors Issues Letter to ShareholdersDecember 8, 2023 | finance.yahoo.comCITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEESDecember 7, 2023 | finance.yahoo.comLeading Independent Proxy Advisory Firm ISS Recommends Check-Cap Shareholders Vote FOR the Keystone Dental Business Combination AgreementDecember 5, 2023 | finance.yahoo.comCHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEESNovember 29, 2023 | benzinga.comCheck-Cap Stock (NASDAQ:CHEK) Earnings Dates and Earning CallsNovember 28, 2023 | benzinga.comCheck-Cap Stock (NASDAQ:CHEK) Dividends: History, Yield and DatesNovember 27, 2023 | benzinga.comCheck-Cap: Q3 Earnings InsightsNovember 27, 2023 | msn.comCheck-Cap GAAP EPS of -$0.44November 27, 2023 | markets.businessinsider.comCheck-Cap Posts Narrower Loss In Q3 - Quick FactsNovember 27, 2023 | finance.yahoo.comCheck-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate UpdateNovember 7, 2023 | morningstar.comCheck-Cap Ltd CHEKOctober 31, 2023 | markets.businessinsider.comNotice of Extraordinary General Meeting of ShareholdersOctober 27, 2023 | msn.comCheck out some of the caps you can get at a Bucks game this yearOctober 26, 2023 | bloomberg.comKazakhstan Aims to Cut Loan-Rate CapSee More Headlines Receive CHEK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/27/2023Today5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry X - ray apparatus & tubes Sub-IndustryN/A Current SymbolNASDAQ:CHEK CUSIPN/A CIK1610590 Webwww.check-cap.com Phone972546706451Fax972-4821-1267Employees85Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-47.85% Return on Assets-43.50% Debt Debt-to-Equity RatioN/A Current Ratio17.60 Quick Ratio17.60 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$8.57 per share Price / Book0.25Miscellaneous Outstanding Shares5,850,000Free Float5,822,000Market Cap$12.69 million OptionableNot Optionable Beta0.45 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Alex Ovadia (Age 62)CEO & Director Comp: $409.35kDr. Yoav Kimchy Ph.D. (Age 63)Founder & Interim CTO Comp: $362.65kMr. Joshua Belkar (Age 55)Vice President of Operations Comp: $269.57kMs. Iris Even-TovInterim Chief Financial OfficerMs. Noa Reshef M.B.A.Director of Human ResourcesKey CompetitorsPurple BiotechNASDAQ:PPBTBIMINASDAQ:BIMICoeptis TherapeuticsNASDAQ:COEPOntrakNASDAQ:OTRKKiora PharmaceuticalsNASDAQ:KPRXView All Competitors CHEK Stock Analysis - Frequently Asked Questions Should I buy or sell Check-Cap stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares. View CHEK analyst ratings or view top-rated stocks. How have CHEK shares performed in 2024? Check-Cap's stock was trading at $2.08 on January 1st, 2024. Since then, CHEK stock has increased by 4.3% and is now trading at $2.17. View the best growth stocks for 2024 here. How were Check-Cap's earnings last quarter? Check-Cap Ltd. (NASDAQ:CHEK) announced its earnings results on Monday, November, 27th. The medical research company reported ($0.44) earnings per share for the quarter, topping the consensus estimate of ($0.83) by $0.39. When did Check-Cap's stock split? Shares of Check-Cap reverse split before market open on Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Check-Cap own? Based on aggregate information from My MarketBeat watchlists, some companies that other Check-Cap investors own include Alibaba Group (BABA), Navios Maritime Partners (NMM), New Residential Investment (NRZ), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Acasti Pharma (ACST), Avinger (AVGR), Biocept (BIOC) and Purple Biotech (KTOV). When did Check-Cap IPO? Check-Cap (CHEK) raised $13 million in an IPO on Thursday, February 19th 2015. The company issued 1,200,000 shares at $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager. How do I buy shares of Check-Cap? Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CHEK) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable ProsperityYou need to know these two things about AI stocks ASAP…InvestorPlaceGold ManiaStansberry ResearchShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.